Open enrollment has started and the median premium increase is 1.1%, according to the Kaiser Family Foundation.
The open enrollment period for the ACA exchanges started yesterday and premiums are, for the most part, holding steady.
According to the Kaiser Family Foundation, half of the rate changes of coverage sold on Healthcare.gov or the 15 state-run exchanges fall between a 3.5% decrease and 4.6% increase. The median rate change is a 1.1%, according to the Kaiser’s number.
Some insurers are edging rates up because they are anticipating costs associated with the COVID-19, COVID-19 TESTING, a rebound of the utilization of medical services that people put off in 2020, and an increase in ]illness because of forgone preventive services, according to the foundation's report.
Others, though, see a continuation of diminished demand for medical services because of the COVID-19 pandemic, social distancing and a continuance of the reluctance to seek in-person care.
Put them together and it's a wash.
“Most premium changes on the ACA marketplaces will be modest heading into 2021, even with the uncertainty surrounding the pandemic,” says the Kaiser report, which was published on Oct 19. Insurers selling in the individual market have remained profitable and medical-loss ratios have been low because of low utilization so large premium hikes would have been hard to justify, says the Kaiser report.
Still, there are some outliers. In Alabama, Bright Health Insurance is bumping up its premium by 25.6%.
Wellmark Health Plan of Iowa is an outlier in the the direction; it's slashing its ACA premium by 42%.
Kaiser report is based on rate filings at state-level insurance departments as of October 15.
The open enrollment ends on December 15 in the 36 states that are using Healthcare.gov. The closing dates varies in the 14 states, plus Washington, D.C., that have their own state-run exchanges.
In 2020, about 11. 4 million Americans are covered by plans that were purchased either through the federal government’s exchange, Healthcare.gov, or through one of the state-run exchanges, according to an official tally issued by CMS in April. That is roughly the same number who were covered through exchange plans in 2019. The average monthly premium was $595 although after ACA subsidies were applied, the average net premium was $89.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
2 Clarke Drive
Cranbury, NJ 08512